Literature DB >> 23007495

The MicroRNA.

Shao-Yao Ying1, Donald C Chang, Shi-Lung Lin.   

Abstract

MicroRNAs (miRNAs), widely distributed, small regulatory RNA genes, target both messenger RNA (mRNA) degradation and suppression of protein translation based on sequence complementarity between the miRNA and its targeted mRNA. Different names have been used to describe various types of miRNA. During evolution, RNA retroviruses or transgenes invaded the eukaryotic genome and inserted itself in the noncoding regions of DNA, conceivably acting as transposon-like jumping genes, providing defense from viral invasion and fine-tuning of gene expression as a secondary level of gene modulation in eukaryotes. When a transposon is inserted in the intron, it becomes an intronic miRNA, taking advantage of the protein synthesis machinery, i.e., mRNA transcription and splicing, as a means for processing and maturation. Recently, miRNAs have been found to play an important, but not life-threatening, role in embryonic development. They might play a pivotal role in diverse biological systems in various organisms, facilitating a quick response and accurate plotting of body physiology and structures. Based on these unique properties, manufactured intronic miRNAs have been developed for in vitro evaluation of gene function, in vivo gene therapy, and generation of transgenic animal models. The biogenesis and identification of miRNAs, potential applications, and future directions for research are presented in this chapter, hopefully providing a guideline for further miRNA and gene function studies.

Mesh:

Substances:

Year:  2013        PMID: 23007495     DOI: 10.1007/978-1-62703-083-0_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export.

Authors:  Matthew B Hudson; Myra E Woodworth-Hobbs; Bin Zheng; Jill A Rahnert; Mitsi A Blount; Jennifer L Gooch; Charles D Searles; S Russ Price
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

2.  Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.

Authors:  Min Luo; Dongxiang Shen; Wei Wang; Jiang Xian
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 3.  Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications.

Authors:  Yaoliang L Tang; Yingjie J Wang; Lijuan J Chen; Yaohua H Pan; Lan Zhang; Neal L Weintraub
Journal:  Exp Biol Med (Maywood)       Date:  2013-03

4.  MicroRNA-1246 regulates proliferation, invasion, and differentiation in human vascular smooth muscle cells by targeting cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  Diguang Pan; Guiyong Liu; Bin Li; Jingbo Jiang; Wei Chen; Wei Li; Lin Zhang; Yubao Hu; Shuyun Xie; Huayun Yang
Journal:  Pflugers Arch       Date:  2021-01-08       Impact factor: 3.657

5.  Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.

Authors:  Manish Kumar; Ajay Matta; Olena Masui; Gunjan Srivastava; Jatinder Kaur; Alok Thakar; Nootan Kumar Shukla; Ajoy RoyChoudhury; Meherchand Sharma; Paul G Walfish; K W Michael Siu; Shyam Singh Chauhan; Ranju Ralhan
Journal:  J Transl Med       Date:  2015-08-30       Impact factor: 5.531

6.  Screening of MicroRNA as potential CardiomiRs in Rattus noveregicus Heart related Dataset.

Authors:  Yashika Rustagi; Vibha Rani
Journal:  Bioinformation       Date:  2013-11-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.